Meticulous Research®, a prominent market research firm, has published a new report titled "Microbiology Testing Market by Product (PCR, Mass Spectrometer, HPLC, Stainer, Incubator, Microscopes, Kits, Reagents), Microorganism (Bacteria, Fungi, Virus), Application (Pharmaceutical, F&B, Environment, Cosmetic), End User - Global Forecast to 2030."

According to the report, the global microbiology testing market is expected to reach $21.4 billion by 2030, growing at a CAGR of 5.9% from 2024 to 2030. Key drivers of this market include the increasing burden of infectious diseases, frequent outbreaks of epidemics, stringent regulatory requirements for microbial contamination in pharmaceutical and food & beverage manufacturing, technological advancements in microbiology testing, and rising public and private funding for infectious disease research. However, the market growth is expected to be restrained by the high cost of microbiological instruments.

Download Free Sample Research PDF @ https://www.meticulousresearch.com/download-sample-report/cp_id=5462

Market Segmentation Overview

The global microbiology testing market is segmented by product, microorganism type, application, end user, and geography.

Product Segment:

• Laboratory Instruments and Analyzers
• Kits and Reagents
• Other Products

In 2024, the laboratory instruments and analyzers segment is projected to hold the largest market share, driven by increasing funding for infectious disease research and ongoing technological advancements in microbiology testing.

Microorganism Type Segment:

• Bacteria
• Fungi
• Other Microorganism Types

The bacteria segment is expected to dominate in 2024, owing to the significant number of foodborne diseases caused by bacteria and strict regulations regarding bacterial contamination in food and beverage manufacturing.

Application Segment:

• Pharmaceutical Testing
• Diagnostic Testing
• Food & Beverage Testing
• Environmental Testing
• Cosmetic Testing
• Other Applications

The diagnostic testing segment is anticipated to account for the largest share of the market in 2024, driven by the increasing prevalence of infectious diseases, advancements in microbiology testing technologies, growing awareness of early disease diagnosis, and rising healthcare expenditure.

End User Segment:

• Hospitals and Diagnostic Labs
• Analytical and Quality Laboratories
• Academic & Research Institutes

Hospitals and diagnostic labs are expected to lead the market in 2024, primarily due to the prevalence of infectious diseases such as COVID-19, malaria, dengue, gastrointestinal infections, tuberculosis, and HIV, as well as technological advancements in microbiology testing, particularly in automation.

Geographic Segment:

• North America (U.S. and Canada)
• Europe (Germany, France, U.K., Italy, Spain, Switzerland, and the Rest of Europe)
• Asia-Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia-Pacific)
• Latin America (Brazil, Mexico, Argentina, and the Rest of Latin America)
• Middle East & Africa (South Africa, U.A.E., Saudi Arabia, and the Rest of Middle East & Africa)

Quick Buy – Microbiology Testing Market - Global Opportunity Analysis and Industry Forecast (2024-2030), Research Report: https://www.meticulousresearch.com/Checkout/35599912

Key Players

The report identifies the leading companies in the microbiology testing market, including bioMérieux SA (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Bruker Corporation (U.S.), Hologic, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Intertek Group plc (U.K.), Eurofins Scientific S.E. (Luxembourg), and Agilent Technologies, Inc. (U.S.).

Contact Us:
Meticulous Research^®
Email- [email protected]
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research